Delivery Order SPE2DB24D2106-SPE2DB25FAVAE

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,136.96 firm fixed-price contract is for the supply of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract has an ultimate completion date of July 11, 2023 and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,095.47, is for the supply of 4564135191 DEXTROAMP-AMPHET ER 10 MG CAP 100S. The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue...
This federal contract award, valued at $1,708.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565476077 - DEXTROAMP-AMPHETAMIN 10 MG TAB 100S, with a completion date of August 19, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,004.92 firm fixed-price delivery order (SPE2DX15D9762|SPE2DX25FPFWM) is for the supply of 4566677228 ! DEXT-AMPHETA 10MG 100S and has an ultimate completion date of December 10, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,530.05 firm fixed-price contract is for the delivery of 4,558,698,205 dextroamphetamine-amphetamine 5 mg tablets to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 7, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,581.84 firm fixed-price contract is for the delivery of 4,566,225,721 units of dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of October 28, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,360.58, is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order, with a performance period extending to February 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,070.16 firm fixed-price contract is for the delivery of 100 units of 40 mg lisdexamfetamine capsules. The contract has an ultimate completion date of March 20, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $59,037.15 and a performance period ending on July 19, 2024. DMS Pharmaceutical Group is a pharmaceutical wholesaler that specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAVAE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,165.33, is for the delivery of 4567933939 DEXTROAMP-AMPHET ER 20 MG CAP 100S and has an ultimate completion date of April 16, 2025. DMS Pharmaceutical Group Inc. is the prime contractor, and there are no mentioned subcontractors. The contract is not associated with a larger vehicle and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

Generated 7/15/25, 3:59 PM